Endothelial Progenitor Cells Dysfunction and Impaired Tissue Reparation: The Missed Link in Diabetes Mellitus Development
Overview
Authors
Affiliations
Diabetes mellitus (DM) is considered a leading cause of premature cardiovascular (CV) mortality and morbidity in general population and in individuals with known CV disease. Recent animal and clinical studies have shown that reduced number and weak function of endothelial progenitor cells (EPCs) may not only indicate to higher CV risk, but contribute to the impaired heart and vessels reparation in patients with DM. Moreover, EPCs having a protective impact on the vasculature may mediate the functioning of other organs and systems. Therefore, EPCs dysfunction is probably promising target for DM treatment strategy, while the role of restoring of EPCs number and functionality in CV risk diminish and reduce of DM-related complications is not fully clear. The aim of the review is summary of knowledge regarding EPCs dysfunction in DM patients.
The Impact of Modern Anti-Diabetic Treatment on Endothelial Progenitor Cells.
Altabas V, Marinkovic Radosevic J, Spoljarec L, Uremovic S, Bulum T Biomedicines. 2023; 11(11).
PMID: 38002051 PMC: 10669792. DOI: 10.3390/biomedicines11113051.
Altabas V, Kirigin Bilos L Int J Mol Sci. 2022; 23(5).
PMID: 35269807 PMC: 8910333. DOI: 10.3390/ijms23052663.
Differences of Angiogenesis Factors in Tumor and Diabetes Mellitus.
Tan S, Zang G, Wang Y, Sun Z, Li Y, Lu C Diabetes Metab Syndr Obes. 2021; 14:3375-3388.
PMID: 34335038 PMC: 8318726. DOI: 10.2147/DMSO.S315362.
Yang Y, Zhou Y, Wang Y, Wei X, Wu L, Wang T Acta Diabetol. 2020; 57(11):1315-1326.
PMID: 32556532 DOI: 10.1007/s00592-020-01551-3.
Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes.
Li H, OMeara M, Zhang X, Zhang K, Seyoum B, Yi Z Diabetes. 2019; 68(6):1287-1302.
PMID: 30885990 PMC: 6610016. DOI: 10.2337/db18-0933.